Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | PDCD1 | Q15116 | 4/20 | 0.35 |
| ▸ | CD274 | Q9NZQ7 | 4/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3666063 | 0.81 | SMN1; SMN2 (0.51) | SMN1; SMN2PDCD1CD274ALDH1A1TSHR | |
| SCHEMBL3666546 | 0.77 | PRMT6 (0.48) | SMN1; SMN2PDCD1CD274SCN8A | |
| SCHEMBL7652647 | 0.75 | GSR (0.46) | CHRM2GSRSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL30635465 | 0.75 | CHRM2 (0.43) | CHRM2GSRSMN1; SMN2CYP1A2CYP2D6 | |
| SCHEMBL28152344 | 0.75 | — | — | |
| SCHEMBL3667596 | 0.72 | MEN1 (0.43) | CHRM2SMN1; SMN2PDCD1CD274ALDH1A1 | |
| SCHEMBL4051279 | 0.70 | CYP1A2 (0.74) | CHRM2SMN1; SMN2CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL29870183 | 0.70 | CYP1A2 (0.74) | CHRM2SMN1; SMN2CYP1A2CYP2D6ALDH1A1 | |
| SCHEMBL3516514 | 0.70 | NPSR1 (0.43) | SMN1; SMN2ALDH1A1NPSR1 | |
| Hydrochloric Acid SCHEMBL6264264 | 0.69 | CYP1A2 (0.71) | CHRM2CYP1A2CYP2D6ALDH1A1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117083279-A | Oxazepine compounds and their use in the treatment of cancer | 基因泰克公司 | 2023-11-17 | — | — | CN | disclosed |